Toggle Menu

Press Room

Cool trend in IR practice looks for warm reception

08/01/2008

The hottest trend in interventional radiology is also its coldest. Improved technology and growing clinical experience have moved cryoablation into mainstream IR practice. Cryoprobes used to be too large to allow perutaneous intervention. But Endocare (Irvine, CA) recently introduced a 1.7-mm diameter device about one-quarter the size of the previous generation. The industrial leap has made percutaneous image-guided cryoablation possible, said Dr. J. Louis Hinshaw, an interventionalist and assistant professor of abdominal imaging at the University of Wisconsin-Madison. Source: CMP Healthcare Media Group LLC, Diagnostic Imaging Magazine

A new kind of patient advocate

08/01/2008

Source: Pharmafocus.com

Check out these recent interviews with medical experts provided by Patient Power!

08/01/2008

Uplifting Athletes at Ohio State Raises Awareness for Kidney Cancer

07/31/2008

Inaugural event a great experience for players and fans

Ohio State Football Uplifting Athletes to Host Video Game Tournament

07/30/2008

Ohio State football student-athletes have started a student organization called Uplifting Athletes, joining other college football programs in an effort to make rare diseases better known. Their first event will be a college football video game tournament on Wednesday, July 30, at Eddie George's Grille 27 from 4 - 8 p.m. The event will raise funds for the Kidney Cancer Association and increase awareness for this rare disease.

Medicare changes threaten clinics' survival

07/30/2008

Lawmakers Agree to Ban Toxins in Children's Items

07/29/2008

Survivor raises funds for Kidney Cancer Association

07/27/2008

Two year survivor Ashraf Khalil is selling homemade Hummus and Baba Ghanoog to benefit the Kidney Cancer Association. Please read below for more information.

New treatment option for kidney cancer

07/24/2008

NEW YORK – July 24, 2008 – Patients treated for kidney cancer that has spread to other organs live longer without the cancer advancing when treated with a new drug, researchers say. The new drug is called everolimus and the study led by Dr. Robert Motzer, of Memorial Sloan-Kettering Cancer Center, showed that the drug prolongs progression-free survival relative to placebo in patients who have experienced treatment failure on other regimens. The results of the study appear yesterday in an early online edition of The Lancet. Source: Cancerfacts.com

Conductor James Levine had malignant kidney growth

07/23/2008

BOSTON — A growth on a kidney removed from conductor James Levine was malignant, but the cancer was caught early and no further treatment is needed, the Boston Symphony Orchestra said Tuesday. Source: Foxnews.com

Previous  |  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52  |  53  |  54  |  55  |  56  |  57  |  58  |  59  |  60  |  61  |  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  |  80  |  81  |  82  |  83  |  84  |  85  |  86  |  87  |  88  |  89  |  90  |  91  |  92  |  93  |  94  |  95  |  96  |  97  |  98  |  99  |  100  |  101  |  102  |  103  |  104  |  105  |  106  |  107  |  108  |  109  |  110  |  111  |  112  |  113  |  114  |  115  |  116  |  117  |  118  |  119  |  120  |  121  |  122  |  123  |  124  |  125  |  126  |  127  |  128  |  129  |  130  |  131  |  132  |  133  |  134  |  135  |  136  |  137  |  138  |  139  |  140  |  141  |  142  |  143  |  144  |  145  |  146  |  147  |  148  |  149  |  150  |  151  |  152  |  153  |  154  |  155  |  156  |  157  |  158  |  159  |  160  |  161  |  162  |  163  |  164  |  165  |  166  |  167  |  168  |  169  |  170  |  171  |  172  |  173  |  174  |  175  |  176  |  177  |  178  |  179  |  180  |  181  |  182  |  183  |  184  |  185  |  186  |  187  |  188  |  189  |  190  |  191  |  192  |  193  |  194  |  195  |  196  |  197  |  198  |  199  |  200  |  201  |  202  |  203  |  204  |  205  |  206  |  207  |  208  |  209  |  210  |  211  |  212  |  213  |  214  |  215  |  216  |  217  |  218  |  219  |  220  |  221  |  222  |  223  |  224  |  225  |  226  |  227  |  228  |  229  |  230  |  231  |  232  |  233  |  234  |  235  |  236  |  237  |  238  |  239  |  240  |  241  |  242  |  243  |  244  |  245  |  246  |  247  |  248  |  249  |  250  |  251  |  252  |  253  |  254  |  255  |  256  |  257  |  258  |  259  |  260  |  261  |  262  |  263  |  264  |  265  |  266  |  267  |  268  |  269  |  270  |  271  |  272  |  273  |  274  |  275  |  276  |  277  |  278  |  279  |  280  |  281  |  282  |  283  |  284  |  285  |  286  |  287  |  288  |  289  |  290  |  291  |  292  |  293  |  294  |  295  |  296  |  297  |  298  |  299  |  300  |  301  |  302  |  303  |  304  |  305  |  306  |  307  |  308  |  309  |  310  |  311  |  312  |  313  |  314  |  315  |  316  |  317  |  318  |  319  |  320  |  321  |  322  |  323  |  324  |  325  |  326  |  327  |  328  |  329  |  330  |  331  |  332  |  333  |  334  |  335  |  336  |  337  |  338  |  339  |  340  |  341  |  342  |  343  |  344  |  345  |  346  |  347  |  348  |  349  |  350  |  351  |  352  |  353  |  354  |  355  |  356  |  357  |  358  |  359  |  360  |  361  |  362  |  363  |  364  |  Next
NeonCRM by Neon One